Preventing depression after stroke

International Review of Psychiatry

Volumn 18, Issue 5, 2006, Pages 471-481

  Whyte, Ellen M ^a,d   Mulsant, Benoit H ^a,b   Rovner, Barry W ^c   Reynolds, Charles F ^a,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c Jefferson Hospital for Neuroscience   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

BEHAVIOR THERAPY; BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE THERAPY; CONCEPTUAL FRAMEWORK; ECCHYMOSIS; EPISTAXIS; GENERAL ASPECTS OF DISEASE; HEMORRHOID HEMORRHAGE; HUMAN; MAJOR DEPRESSION; MENORRHAGIA; MENTAL DISEASE; MENTAL HEALTH RESEARCH; PETECHIA; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PSYCHOTHERAPY; PUERPERAL DEPRESSION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; VASOCONSTRICTION;

CEREBROVASCULAR ACCIDENT; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; MENTAL HEALTH; SEROTONIN UPTAKE INHIBITORS;

EID: 33750631025     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260600935470     Document Type: Review

References (83)

1. American Heart Association. (2002). Heart and stroke statistical update. American Heart Association, 2001, Dallas, Texas.
2. Andersen, G., Vestergaard, K., & Lauritzen, L. (1994). Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 25(6), 1099-1104.
3. Andersen, G., Vestergaard, K., & Riis, J. (1993). Citalopram for post-stroke pathological crying. Lancet, 342(8875), 837-839.
4. Bak, S., Tsiropoulos, I., Kjaersgaard, J. O., Andersen, M., Mellerup, E., Hallas, J., et al. (2002). Selective serotonin reuptake inhibitors and the risk of stroke: A population based case-control study. Stroke, 33(6), 1465-1473.
5. Bechdolf, A., Phillips, L. J., Francey, S. M., Leicester, S., Morrison, A. P., Veith, V., et al. (2006). Recent approaches to psychological interventions for people at risk of psychosis. European Archives of Psychiatry and Clinical Neuroscience, 256(3), 159-173.
6. Bolla-Wilson, K., Robinson, R. G., Starkstein, S. E., Boston, J., & Price, T. R. (1989). Lateralization of dementia of depression in stroke patients. American Journal of Psychiatry, 146(5), 627-634.
7. Burton, C., & Gibbon, B. (2005). Expanding the role of the stroke nurse: A pragmatic clinical trial. Journal of Advanced Nursing, 52(6), 640-650.
8. Call, G. K., Fleming, M. C., Sealfon, S., Levine, H., Kistler, J. P., & Fisher, C. M. (1988). Reversible cerebral segmental vasoconstriction. Stroke, 19(9), 1159-1170.
9. Caplan, G (1964). Principles of preventive psychiatry. New York: Basic Books.
10. Carney, R. M., Saunders, R. D., Freedland, K. E., Stein, P., Rich, M. W., & Jaffe, A. S. (1995a). Association of depression with reduced heart rate variability in coronary artery disease. American Journal of Cardiology, 76(8), 562-564.
11. Carney, R. M., Freedland, K. E., Eisen, S. A., Rich, M. W., & Jaffe, A. S. (1995b). Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology, 14(1), 88-90.
12. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386-389.
13. Charney, D. S., Reynolds III, C. F. III, Lewis, L., Lebowitz, B. D., Sunderland, T., Alexopoulos, G. S., et al. (2003). Depression and bipolar support alliance consensus statement on the unmet needs and diagnosis and treatment of mood disorders in late life. Archives of General Psychiatry, 60(7), 664-672.
14. Chemerinski, E., Robinson, R. G., Arndt, S., & Kosier, J. T. (2001). The effect of remission of post-stroke depression on activities of daily living in a double-blind randomized treatment study. Journal of Nervous and Mental Disease, 189(7), 421-425.
15. Cicerone, K. D., Dahlberg, C., Kalmar, K., Langenbahn, D. M., Malec, J. F., Bergquist, T. F., et al. (2000). Evidence-based cognitive rehabilitation: Recommendations for clinical practice. Archives of Physical Medicine and Rehabilitation, 81(12), 1596-1615.
16. Commission on Chronic Illness (1957). Chronic illness in the United States. Cambridge, MA: Harvard University Press.
17. Compton, M. T. (2004). Considering schizophrenia from a prevention perspective. American Journal of Preventive Medicine, 26(2), 178-185.
18. Conde Lopez, V. J., Ballesteros Alcalde, M. C., Blanco Garrote, J. A., & Marco Llorente, J. (1998). Cerebral Infarction in an adolescent girl following an overdose of paroxetine and caffedrine combined with theodrenaline. Actas Luso-espanolas de Neurologia Psiquiatria Ciencias Afines, 26, 333-338.
19. Dam, M., Tonin, P., De Boni, A., Pizzolato, G., Casson, S., Ermani, M., et al. (1996). Effects of fluoxetine and maprotiline on functional recovery in post-stroke hemiphlegic patients undergoing rehabilitation therapy. Stroke, 27(7), 1211-1214.
20. Dam, H. (2001). Depression in stroke patients 7 years following stroke. Acta Psychiatrica Scandinavica, 103(4), 287-293.
21. De Abajo, F. J., Jick, H., Derby, L., Jick, S., & Schmitz, S. (2000). Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. British Journal of Clinical Pharmacology, 50(1), 43-47.
22. Dennis, C. L., & Creedy, D. (2004). Psychosocial and psychological interventions for preventing postpartum depression. Cochrane database of systematic reviews, 18, CD001134.
23. Downhill, J., & Robinson, R. (1994). Longitudinal assessment of depression and cognitive impairment following stroke. Journal of Nervous and Mental Disease, 182(8), 425-431.
24. Ebrahim, S., Barer, D., & Nouri, F. (1986). Use of the Nottingham health profile with patients after a stroke. Journal of Epidemiology and Community Health, 40(2), 166-169.
25. Forster, A., & Young, J. (1996). Specialist nurse support for patients with stroke in the community: A randomised controlled trial. British Medical Journal, 312(7047), 1642-1646.
26. Goldberg, G., Segal, M. E., Berk, S. N., Schall, R. R., & Gershkoff, A. M. (1997). Stroke transition after inpatient rehabilitation. Topics in Stroke Rehabilitation, 4(1), 64-79.
27. Gonzales-Torrecillas, J., Mendlewicz, J., & Lobo, A. (1995). Effects of early treatment of post-stroke depression on neuropsychological rehabilitation. International Psychogeriatrics, 7(4), 547-560.
28. Gordon, R. (1987). An operational classification of disease prevention. In J. Steinberg & M. Silverman (Eds.), Preventing mental disorders: A research perspective. Rockville, MD: NIMH.
29. Hegel, M. T., Barrett, J. E., & Oxman, T. E. (2000). Training therapists in problem-solving treatment of depressive disorders in primary care: Lessons learned from the 'Treatment Effective Project'. Families, Systems and Health, 18, 423-439.
30. House, A. (2000). The treatment of depression after stroke. Journal of Psychosomatic Research, 48(3), 235.
31. House, A., Knapp, P., Bamford, J., & Vail, A. (2001). Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke, 32, 696-701.
32. Jacobi, C., Hayward, C., De Zwaan, M., Kraemer, H. C., & Agras, W. S. (2004). Coming to terms with risk factors for eating disorders: Application of risk terminology and suggestions for a general taxonomy. Psychological Bulletin, 130(1), 19-65.
33. Jorge, R. E., Robinson, R. G., Arndt, S., & Starkstein, S. (2003). Mortality and post stroke depression: A placebo-controlled trial of antidepressants. American Journal of Psychiatry, 160(10), 1823-1829.
34. Kazdin, A. E., Kraemer, H. C., Kessler, R. C., Kupfer, D. J., & Offord, D. R. (1997). Contributions of risk-factor research to developmental psychopathology. Clinical Psychology Review, 17(4), 375-406.
35. Kendler, K. S., Kuhn, J. W., Vittum, J., Prescott, C. A., & Riley, B. (2005). The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Archives of General Psychiatry, 62(5), 529-535.
36. Kishi, Y., Kosier, J. T., & Robinson, R. G. (1996a). Suicidal plans in patients with acute stroke. Journal of Nervous & Mental Disease, 184(5), 274-280.
37. Kishi, Y., Robinson, R. G., & Kosier, J. T. (1996b). Suicidal plans in patients with stroke: Comparison between acute-onset and delayed-onset suicidal plans. International Psychogeriatrics, 8(4), 623-634.
38. Kneebone, I., & Dunmore, E. (2000). Psychological management of post-stroke depression. British Journal of Clinical Psychology, 39(Pt1), 53-65.
39. Kotila, M., Waltimo, O., Niemi, M. L., Laaksonen, R., & Lempinen, M. (1984). The profile of recovery from stroke and factors influencing outcome. Stroke, 15(6), 1039-1044.
40. Kraemer, H. C., Kazdin, A. E., Offord, D. R., Kessler, R. C., Jensen, P. S., & Kupfer, D. J. (1997). Coming to terms with the terms of risk. Archives of General Psychiatry, 54(4), 337-343.
41. Kraemer, H. C., Stice, E., Kazdin, A., Offord, D., & Kupfer, D. (2001). How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry, 158(6), 848-856.
42. Lenze, E. J., Munin, M. C., Ferrell, R. E., Pollock, B. G., Skidmore, E., Lotrich, F., et al. (2005). Association of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) genotype with depression in elderly persons after hip fracture. American Journal of Geriatric Psychiatry, 13(5), 428-432.
43. Lesperance, F., Frasure-Smith, N., Theroux, P., & Irwin, M. (2004). The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. American Journal of Psychiatry, 161(2), 271-277.
44. Lipsey, J. R., Robinson, R. G., Pearlson, G. D., Rao, K., & Price, T. R. (1984). Nortriptyline treatment of post-stroke depression: A double blind study. Lancet, 1, 297-300.
45. Markovitz, J. H., Shuster, J. L., Chitwood, W. S., May, R. S., & Tolbert, L. C. (2000). Platelet activation in depression and effects of sertraline treatment: An open-label study. American Journal of Psychiatry, 157(6), 1006-1008.
46. McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with sub-threshold symptoms. Archives of General Psychiatry, 59(10), 921-928.
47. Miller, G. E., Stetler, C. A., Carney, R. M., Freedland, K. E., & Banks, W. A. (2002). Clinical depression and inflammatory risk markers for coronary heart disease. American Journal of Cardiology, 90(12), 1279-1283.
48. Morris, P. L., Robinson, R. G., Andrzejewski, P., Samuels, J., & Price, T. R. (1993b). Association of depression with 10-year post-stroke mortality. American Journal of Psychiatry, 150(1), 124-129.
49. Molaie, M. (1997). Serotonin syndrome presenting with migraine-like stroke. Headache, 37(8), 519-521.
50. Morris, P. L., Robinson, R. G., & Samuels, J. (1993a). Depression, introversion and mortality following stroke. The Australian and New Zealand Journal of Psychiatry, 27(3), 443-449.
51. Moulin, T., Crepin-Leblond, T., Chopard, J. L., & Bogousslavsky, J. (1994). Hemorrhagic infarcts. European Neurology, 34(2), 64-77.
52. Muller, U., Murai, T., Bauer-Wittmund, T., & Von Cramon, D. Y. (1999). Paroxetine vs citalopram treatment of pathological crying after brain injury. Brain Injury, 13(10), 805-811.
53. Mzarek P, Haggerty R. (Eds.). Reducing risks for mental disorders: Frontiers for preventive intervention research. National Academy Press: Washington DC; 1994.
54. Narushima, K., Kosier, J., & Robinson, R. (2002). Preventing post-stroke depression: A 12-week double-blind randomized treatment trial and 21-month follow-up. Journal of Nervous and Mental Disease, 190(5), 296-303.
55. National Institutes of Mental Health (NIMH). (2002). Breaking ground, breaking through: The strategic plan for mood disorders research. Bethesda, MD: NIMH.
56. Niedermaier, N., Bohrer, E., Schulte, K., Schlattmann, P., & Heuser, I. (2004). Prevention and treatment of post-stroke depression with mirtazapine in patients with acute stroke. Journal of Clinical Psychiatry, 65(12), 1619-1623.
57. Nikisch, G., Mathe, A. A., Czernik, A., Thiele, J., Bohner, J., Eap, C. B., et al. (2005). Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: Relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl), 181(4), 751-760, Epub 2005 Sep 29.
58. Palomaki, H., Kaste, M., Berg, A., Lonnqvist, R., Lonnqvist, J., Lehtihalmes, M., et al. (1999). Prevention of post-stroke depression: 1-year randomised placebo controlled double blind trial of mianserin with 6-month follow-up after therapy. Journal of Neurology Neurosurgery & Psychiatry, 66(4), 490-494.
59. Paolucci, S., Antonucci, G., Pratesi, L., Traballesi, M., Lubich, S., & Grasso, M. G. (1998). Functional outcome in stroke inpatient rehabilitation: Predicting no, low and high response patients. Cerebrovascular Diseases, 8(4), 228-234.
60. Paolucci, S., Antonucci, G., Grasso, M. G., Morelli, D., Troisi, E., Coiro, P., et al. (2001). Post-stroke depression, antidepressant treatment and rehabilitation results. A casecontrol study. Cerebrovascular Diseases, 12(3), 264-271.
61. Pariente, J., Loubinoux, I., Carel, C., Albucher, J. F., Leger, A., Manelfe, C., et al. (2001). Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Annals of Neurology, 50(6), 718-729.
62. Parikh, R., Robinson, R., Lipsey, J., Starkstein, S. E., Fedoroff, J. P., & Price, T. R. (1990). The impact of post-stroke depression on recovery in activities of daily living over a 2-year follow-up. Archives of Neurology, 47(7), 785-789.
63. Pohjasvaara, T., Vataja, R., Leppavuori, A., Kaste, M., & Erkinjuntti, T. (2001a). Suicidal ideas in stroke patients 3 and 15 months after stroke. Cerebrovascular Diseases, 12(1), 21-26.
64. Pohjasvaara, T., Vataja, R., Leppavuori, A., Kaste, M., & Erkinjuntti, T. (2001b). Depression is an independent predictor of poor long-term functional outcome post-stroke. European Journal of Neurology, 8(4), 315-319.
65. Prigerson, H. G., Monk, T. H., Reynolds III, C. F. III, Begley, A., Houck, P. R., Bierhals, A. J., et al. (1995/1996). Lifestyle regularity and activity level as protective factors against bereavement-related depression in late-life. Depression, 3, 297-302.
66. Ramasubbu, R. (2004). Cerebrovascular effects of selective serotonin reuptake inhibitors: A systematic review. Journal of Clinical Psychiatry, 65(12), 1642-1653.
67. Rasmussen, A., Lunde, M., Poulsen, D. L., Sorensen, K., Qvitzau, S., & Bech, P. (2003). A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics, 44(3), 216-221,
68. Erratum in: Psychosomatics. 2004, 45(1), 91.
69. Robinson, R., Lipsey, J., Rao, K., & Price, T. R. (1986). Two-year longitudinal study of post-stroke mood disorders: Comparison of acute-onset with delayed-onset depression. American Journal of Psychiatry, 143(10), 1238-1244.
70. Robinson, R. G., Schultz, S. K., Castillo, C., Kopel, T., Kosier, J. T., Newman, R. M., et al. (2000). Nortriptyline vs fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study. American Journal of Psychiatry, 157(3), 351-359.
71. Rovner, B. W. (2006). New opportunities for preventing depression in late-life. Presented at the Annual Meeting of the American Association of Geriatric Psychiatry, 12 March 2006, San Juan, Puerto Rico.
72. Shores, M. M., Pascualy, M., Lewis, N. L., Flatness, D., & Veith, R. C. (2001). Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology, 26(4), 433-439.
73. Singhal, A. B., Caviness, V. S., Begleiter, A. F., Mark, E. J., Rordorf, G., & Koroshetz, W. J. (2002). Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology, 58(1), 130-133.
74. Sinyo, D., Amato, P., Kaloupek, D. G., Becker, R., Goldenberg, M., & Coopersmith, H. (1986). Post-stroke depression: Relationships to functional impairment, coping strategies, and rehabilitation outcomes. Stroke, 17(6), 1102-1107.
75. Toni, D., Fiorelli, M., Bastianello, S., Sacchetti, M. L., Sette, G., Argentino, C., et al. (1996). Hemorrhagic transformation of brain infarct: Predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology, 46(2), 341-345.
76. Van Walraven, C., Mamdani, M. M., Wells, P. S., & Williams, J. I. (2001). Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study. British Medical Journal, 323(7314), 655-658.
77. Van Walraven, C., Hart, R. G., Singer, D. E., Laupacis, A., Connolly, S., Petersen, P., et al. (2002). Oral anticoagulants vs aspirin in non-valvular atrial fibrillation: An individual patient meta-analysis. The Journal of the American Medical Association, 288(19), 2441-2448.
78. Veith, R. C., Lewis, N., Linares, O. A., Barnes, R. F., Raskind, M. A., Villacres, E. C., et al. (1994). Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Archives of General Psychiatry, 51(5), 411-422.
79. Whyte, E. M., & Mulsant, B. H. (2002). Post-stroke depression: Epidemiology, pathophysiology, and biological treatment. Biological Psychiatry, 52(3), 253-264.
80. Whyte, E. M., Puet, T., Mulsant, B. H., Dew, M. A., Begley, A., Reynolds, C. F. III, et al. (2003). Selective serotonin reuptake inhibitors in acute ischemic stroke patients during inpatient rehabilitation. [abstract] Archives of Physical Medicine & Rehabilitation, 84, E5.
81. Whyte, E. M., Mulsant, B. H., Vanderbilt, J., Dodge, H. H., & Ganguli, M. (2004). Depression after stroke: A prospective epidemiological study. Journal of the American Geriatrics Society, 52(5), 774-778.
82. Wiart, L., Petit, H., Joseph, P. A., Mazaux, J. M., & Barat, M. (2000). Fluoxetine in early poststroke depression: A doubleblind placebo-controlled study. Stroke, 31(8), 1829-1832.
83. Williams, L. S., Ghose, S. S., & Swindle, R. W. (2004). Depression and other mental health diagnoses increase mortality risk after ischemic stroke. American Journal of Psychiatry, 161(6), 1090-1095.